These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 38822421)
21. Novel antibodies to phosphorylated α-synuclein serine 129 and NFL serine 473 demonstrate the close molecular homology of these epitopes. Rutherford NJ; Brooks M; Giasson BI Acta Neuropathol Commun; 2016 Aug; 4(1):80. PubMed ID: 27503460 [TBL] [Abstract][Full Text] [Related]
25. alpha-Synucleinopathy models and human neuropathology: similarities and differences. Kahle PJ Acta Neuropathol; 2008 Jan; 115(1):87-95. PubMed ID: 17932682 [TBL] [Abstract][Full Text] [Related]
26. A multiverse of α-synuclein: investigation of prion strain properties with carboxyl-terminal truncation specific antibodies in animal models. Lloyd GM; Quintin S; Sorrentino ZA; Gorion KM; Bell BM; Long B; Paterno G; Giasson BI Acta Neuropathol Commun; 2024 Jun; 12(1):91. PubMed ID: 38858742 [TBL] [Abstract][Full Text] [Related]
27. RT-QuIC Using C-Terminally Truncated α-Synuclein Forms Detects Differences in Seeding Propensity of Different Brain Regions from Synucleinopathies. Poggiolini I; Erskine D; Vaikath NN; Ponraj J; Mansour S; Morris CM; El-Agnaf OMA Biomolecules; 2021 May; 11(6):. PubMed ID: 34072869 [TBL] [Abstract][Full Text] [Related]
28. Prominent microglial inclusions in transgenic mouse models of α-synucleinopathy that are distinct from neuronal lesions. Tanriöver G; Bacioglu M; Schweighauser M; Mahler J; Wegenast-Braun BM; Skodras A; Obermüller U; Barth M; Kronenberg-Versteeg D; Nilsson KPR; Shimshek DR; Kahle PJ; Eisele YS; Jucker M Acta Neuropathol Commun; 2020 Aug; 8(1):133. PubMed ID: 32787922 [TBL] [Abstract][Full Text] [Related]
29. Overexpression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P]αSyn transgenic mice. Diepenbroek M; Casadei N; Esmer H; Saido TC; Takano J; Kahle PJ; Nixon RA; Rao MV; Melki R; Pieri L; Helling S; Marcus K; Krueger R; Masliah E; Riess O; Nuber S Hum Mol Genet; 2014 Aug; 23(15):3975-89. PubMed ID: 24619358 [TBL] [Abstract][Full Text] [Related]
30. Oligodendrocytes Prune Axons Containing α-Synuclein Aggregates In Vivo: Lewy Neurites as Precursors of Glial Cytoplasmic Inclusions in Multiple System Atrophy? De Nuccio F; Kashyrina M; Serinelli F; Laferrière F; Lofrumento DD; De Giorgi F; Ichas F Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830639 [TBL] [Abstract][Full Text] [Related]
31. Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy. Schaser AJ; Stackhouse TL; Weston LJ; Kerstein PC; Osterberg VR; López CS; Dickson DW; Luk KC; Meshul CK; Woltjer RL; Unni VK Acta Neuropathol Commun; 2020 Aug; 8(1):150. PubMed ID: 32859276 [TBL] [Abstract][Full Text] [Related]
32. Effects of Alpha-Synuclein Targeted Antisense Oligonucleotides on Lewy Body-Like Pathology and Behavioral Disturbances Induced by Injections of Pre-Formed Fibrils in the Mouse Motor Cortex. Boutros SW; Raber J; Unni VK J Parkinsons Dis; 2021; 11(3):1091-1115. PubMed ID: 34057097 [TBL] [Abstract][Full Text] [Related]
33. Is Multiple System Atrophy a Prion-like Disorder? Jellinger KA; Wenning GK; Stefanova N Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576255 [TBL] [Abstract][Full Text] [Related]
34. Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports. Lashuel HA Neurobiol Dis; 2020 Jul; 141():104876. PubMed ID: 32339655 [TBL] [Abstract][Full Text] [Related]
35. The emerging role of α-synuclein truncation in aggregation and disease. Sorrentino ZA; Giasson BI J Biol Chem; 2020 Jul; 295(30):10224-10244. PubMed ID: 32424039 [TBL] [Abstract][Full Text] [Related]
36. α-Synuclein strains target distinct brain regions and cell types. Lau A; So RWL; Lau HHC; Sang JC; Ruiz-Riquelme A; Fleck SC; Stuart E; Menon S; Visanji NP; Meisl G; Faidi R; Marano MM; Schmitt-Ulms C; Wang Z; Fraser PE; Tandon A; Hyman BT; Wille H; Ingelsson M; Klenerman D; Watts JC Nat Neurosci; 2020 Jan; 23(1):21-31. PubMed ID: 31792467 [TBL] [Abstract][Full Text] [Related]
37. Endogenous oligodendroglial alpha-synuclein and TPPP/p25α orchestrate alpha-synuclein pathology in experimental multiple system atrophy models. Mavroeidi P; Arvanitaki F; Karakitsou AK; Vetsi M; Kloukina I; Zweckstetter M; Giller K; Becker S; Sorrentino ZA; Giasson BI; Jensen PH; Stefanis L; Xilouri M Acta Neuropathol; 2019 Sep; 138(3):415-441. PubMed ID: 31011860 [TBL] [Abstract][Full Text] [Related]
38. Trehalose does not improve neuronal survival on exposure to alpha-synuclein pre-formed fibrils. Redmann M; Wani WY; Volpicelli-Daley L; Darley-Usmar V; Zhang J Redox Biol; 2017 Apr; 11():429-437. PubMed ID: 28068606 [TBL] [Abstract][Full Text] [Related]
39. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy. Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358 [TBL] [Abstract][Full Text] [Related]
40. Overexpression of α-Synuclein by Oligodendrocytes in Transgenic Mice Does Not Recapitulate the Fibrillar Aggregation Seen in Multiple System Atrophy. Laferrière F; He X; Zinghirino F; Doudnikoff E; Faggiani E; Meissner WG; Bezard E; De Giorgi F; Ichas F Cells; 2020 Oct; 9(11):. PubMed ID: 33138150 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]